Severe Iatrogenic Tricuspid Regurgitation. [PDF]
Amaral Pinto I, Macedo D, Rei Neto R.
europepmc +1 more source
A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study. [PDF]
Wang YZ +5 more
europepmc +1 more source
Central serous chorioretinopathy following intramuscular testosterone therapy in prolactinoma. [PDF]
Jha V, Dutta P, Grossman AB, Bashyal B.
europepmc +1 more source
A Diagnostic Challenge in the Emergency Department: Acute Intermittent Porphyria Unmasked After Cabergoline Exposure. [PDF]
Mina C, Ghanem H, Matar N.
europepmc +1 more source
Ultra-rapid prolactin normalization with cabergoline in a premenopausal woman with epilepsy and giant prolactinoma. [PDF]
Ngougni Pokem P +4 more
europepmc +1 more source
Cabergoline (Velactis®) administration at dry-off enhances milk yield in subsequent lactation of Holstein and Girolando (Gir × Holstein) cows. [PDF]
de Souza AH +6 more
europepmc +1 more source
Beyond inhibition: harnessing the DRD2-VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer. [PDF]
Sahu MR +3 more
europepmc +1 more source
Recurrent nasal bleed as initial presenting complaint: a rare complication of giant prolactinoma in a 39-year-old. [PDF]
Fahim W +5 more
europepmc +1 more source
Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition). [PDF]
Lin S +18 more
europepmc +1 more source
Cabergoline-Resistant Recurrent Macroprolactinoma During Pregnancy: A Case Report and Review of the Literature. [PDF]
Alajpur S +3 more
europepmc +1 more source

